Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and so
United States Agency for International Development
Bill and Melinda Gates Foundation
International AIDS Vaccine Initiative
Emory University
Imperial College London
University of Oxford
Institució Catalana de Recerca i Estudis Avançats
China Scholarship Council
National Commission for Science, Technology and Innovation
Center for AIDS Research, University of Washington
Medical Research Council
European and Developing Countries Clinical Trials Partnership
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and so
Mary Amondi, Pontiano Kaleebu, Michael Mutua, Yama F Mujadidi et al.
Citations
6 citations
Journal
The Lancet Microbe
Topics
HIV Research and Treatment
Field-Weighted Citation Impact (FWCI)
6.22
article
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and so
Mary Amondi, Pontiano Kaleebu, Michael Mutua, Yama F Mujadidi, Jennifer Serwanga, Chama Chanda, Patrick Muhumuza, Leslie Nielsen, Patricia Fast, Mabela Matsoso, Tomáš Hanke, Irène Mugenya, Kundai Chinyenze, Paddy Kafeero, Kelly Ramko, Rose Sajabi, Paola Cicconi, Vincent Basajja, Rose Mahira, Susan Mugaba, Anne Gumbe, Hilda Phiri, William Kidega, Bashir Farah, Eduard J. Sanders, Chishiba Kabengele, Nicola Borthwick, Fred Ogada, R Malogo, Oscar Chirro, Kefa O Bosire, Paramesh Chetty, Freddie Kibengo, Moses Muriuki, Clive M. Michelo, Peter Hayes, Rachel L. Rutishauser, Claire Wenden, Anita Kabarambi, Alison Crook, Molly Glaze, Hester Kuipers, Ben Gombe, Geofrey Oino, Irene Mwangi, Gloria Omosa-Manyonyi, Eunice Wambui Nduati, Ayoub Kakande, Natalia Fernández, Vincent Muturi‐Kioi, William Kilembe, Maria Nakimbugwe, Walter Jaoko, Eddy Sayeed, Brenda Okech, Jeroen de Bont, Jennifer Kanungi, Jill Gilmour, Andrea Baines, Elias Chambula, Peter Ejou, Angella Namuyanja, Vernon Musale, Sally Itwi, Meya Muwowo, Belkis M. Akis Yildirim, Deborah King, Sheba Juma, Edmund G. Wee, Gaudensia Mutua, Annie Moyo, Fatima Mwale, Dan Otieno, Shaun Palmer, Jaquelyn Nyange
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet MicrobeVol. 6(6)
Institutions
Centre for Infectious Disease Research in Zambia (ZM), San Francisco General Hospital (US), International AIDS Vaccine Initiative (US), Kenya Medical Research Institute (KE), Kenya AIDS Vaccine Initiative (KE), Institute of Clinical Research (US), Oxford Technologies (United Kingdom) (GB), Jenner Institute (GB), Imperial College London (GB), Uganda Virus Research Institute (UG)
Funders
United States Agency for International Development, Bill and Melinda Gates Foundation, International AIDS Vaccine Initiative, Emory University, Imperial College London, University of Oxford, Institució Catalana de Recerca i Estudis Avançats, China Scholarship Council, National Commission for Science, Technology and Innovation, Center for AIDS Research, University of Washington, Medical Research Council, European and Developing Countries Clinical Trials Partnership